investigational new drug (IND)
|
|
|
During the preclinical stage of drug development, timelines are critical for the filing of an Investigational New Drug (IND) application within a predetermined timeframe and budget. Evolving market pressures have changed the focus of the drug development industry, accelerating early phases further in order to create late-stage pipeline growth. Given these increasing pressures, understanding how and when to plan your preclinical IND-enabling program is an integral part of meeting specific milestones leading to on-time IND submission.
Learn through our years of experience, unique range of services and best-in-class expertise how we are best suited to help you successfully initiate and complete your IND-enabling program. With our ongoing efforts to improve upon our internal processes and continued focus on scientific excellence and guidance, we are pleased to announce the most cost-effective IND program for our clients.

For your IND guide and full access to our accelerated reporting timelines, including a full-size Gantt chart, please log in to The Source℠. If you are not a member of The Source℠, our new online scientific and educational information center, please click here to register.

Related Information Webinar Replay – Planning and Understanding Your IND Program (January 2012)
For more information about our preclinical capabilities, contact us at askcharlesriver@crl.com.
|
Investigational New Drug, IND, IND Guide, Investigational New Drug Guide, IND filing, IND submission, toxicology, IND program, IND proposal, IND Quote, GLP, lead-in timelines, Gantt, Gantt chart, Gantt timelines, IND toxicology, PRELIMINARY TOXICOLOGY, single dose, toxicity, repeat dose, range-finding, Species Selection, IND-enabling, preclinical, SAFETY PHARMACOLOGY, GENETIC TOXICITY, Safety pharm, safety assessment, gene-tox, genetic toxicology, preclinical IND program
Investigational New Drug (IND) Studies | Preclinical Development | Charles River
Timelines are critical for filing an Investigational New Drug (IND) application in a predetermined timeframe and budget. With years of experience and a unique range of studies, we can help you successfully initiate and complete your IND-enabling program.